Geisinger has become the first health care system in Pennsylvania and among few in the world to earn a prestigious information systems and analytics award from HIMSS Analytics, a global health care information technology market intelligence, research and standards organization, the health system announced.
The HIMSS Analytics Stage 6 Adoption Model for Analytics Maturity (AMAM) award recognizes integrated application of information systems and analytics to improve clinical, operational, research and financial processes for health care.
"Geisinger is proud to join a handful of health care organizations in the world to reach this level of analytics maturity," said Geisinger Chief Information Officer John Kravitz. "We strive to provide our patients with the best possible outcomes through innovative technologies and progressive use of data-driven decisions. Geisinger’s clinically integrated environment ensures data flows seamlessly from one department to another, prioritizing patient care."
HIMSS Analytics developed the AMAM as a methodology to measure and advance an organization's analytics capabilities.This international eight-stage (Stage 0 - Stage 7) model measures the capabilities an organization has gained from the installation of data warehousing technology and data governance to assure validated data as a foundation for traditional and creative applications.
Geisinger has achieved AMAM Stage 6, emphasizing a strong foundation of data content, infrastructure, data governance and analytics competency.
Only two organizations in the world have reached the next, prestigious AMAM Stage 7 — Duke Health and University of North Carolina Health. Geisinger joins Rush Health in Chicago and King Faisal Specialist Hospital & Research Centre in Saudi Arabia as the next Stage 6 achievers.
The recognition complements Geisinger’s recent validation as a clinical inpatient Stage 7 health system, as tracked by the HIMSS Electronic Medical Record Adoption Model (EMRAM). The health system validated at Stage 7 for the outpatient adoption model as well. In contrast to AMAM validations, over 350 organizations have achieved EMRAM Stage 7.
"The future of healthcare delivery is in data analytics and personalized medicine, so we are honored to be recognized by HIMSS Analytics for this achievement," said Dr. Mark Poler, a physician informaticist participating in the HIMSS AMAM validation process. “This continued recognition shows Geisinger is building upon a foundation of improved care quality, safety and efficiency.”